Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Acute myocardial infarction/Infarct myocardial; This is a spontaneous report from a non-contactable consumer downloaded from the Agency Regulatory Authority-WEB, regulatory authority number DE-PEI-CADR2021042553. A 80-year-old male patient received BNT162B2 (COMIRNATY, mRNA TOZINAMERAN), intramuscular on 22Mar2021 (Batch/Lot Number: ER2659) as 0.3 mL, single dose for COVID-19 immunisation. Medical history included ongoing hypertension, high blood pressure, nausea with vomiting and heart failure factors or previous illnesses from unspecified dates. There were no concomitant medications. The patient experienced acute myocardial infarction/infarct myocardial on 30Mar2021. The patient died on 30Mar2021. The patient''s outcome was fatal for acute myocardial infarction. It was not reported if an autopsy was performed. This report is serious - death. Sender Comment (verbatim): Are you or the person concerned known of any allergies? If yes, which? No. Information on risk factors or previous illnesses High blood pressure / nausea with vomiting, heart failure No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Acute myocardial infarction/Infarct myocardial
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166